From Compliance to Confidence: Annex 1 for Small-Batch, High-Value Production
3P innovation’s Robotic Fill-Finish Cell: roboFIL, is a fully flexible, Annex 1–ready platform designed for both liquid and powder applications.
Navigating GMP Annex 1 updates has raised new challenges - especially those working with small batch, high-value products in emerging fields like ATMPs, orphan drugs, and personalised medicines.
This webinar explores how to interpret and apply Annex 1 in real-world fill-finish environments, with a particular focus on aseptic filling of small-volume liquid and powder products. We examine key requirements for contamination control strategies (CCS), environmental and process monitoring, equipment design, and reject handling - all essential for ensuring compliance while maintaining flexibility and efficiency in production.
Tracy Moore, Principal Consultant at TM Pharma and former MHRA inspector, provides expert insight into regulatory expectations and practical approaches. The webinar includes:
- Differences in environmental monitoring requirements for liquid vs powder aseptic filling
- Quality management approach and reject handling
- How to approach risk-based compliance without over-engineering
Meet the speakers
David Johnson
Director of Sales & Marketing
David Johnson leads the Sales and Marketing teams at 3P innovation, with a focus on the company’s pharma equipment portfolio. In his role, David works closely with customers across the pharmaceutical and biotech industries, helping them address the challenges of aseptic processing, Annex 1 compliance, and small-batch fill-finish manufacturing.
Tracy Moore
Founder and CEO at TM Pharma Group Ltd and former MHRA Expert EU GMDP inspector.
Tracy Moore is a seasoned GMP/GDP expert with more than three decades of experience spanning pharmaceutical manufacturing, regulation, and quality systems. From decades in industry to 10 years as an MHRA GMP inspector, rising to Expert and regulatory lead, her portfolio includes major contributions to UK and EU GMP guidance and inspector training programs. Since 2022, she continues to support regulatory compliance through her consultancy, TM Pharma Group.